Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study.
Löhr M, Bago ZT, Bergmeister H, Ceijna M, Freund M, Gelbmann W, Günzburg WH, Jesnowski R, Hain J, Hauenstein K, Henninger W, Hoffmeyer A, Karle P, Kröger JC, Kundt G, Liebe S, Losert U, Müller P, Probst A, Püschel K, Renner M, Renz R, Saller R, Salmons B, Walter I, et al.
Löhr M, et al. Among authors: kundt g.
J Mol Med (Berl). 1999 Apr;77(4):393-8. doi: 10.1007/s001090050366.
J Mol Med (Berl). 1999.
PMID: 10353444
Clinical Trial.
No abstract available.